You just read:

Zacks Analyst Blog Highlights: Myriad Genetics, BioMarin Pharmaceuticals, Abbott Laboratories, AstraZeneca and Sanofi-Aventis

News provided by

Zacks Investment Research, Inc.

Apr 08, 2011, 09:30 ET